Great West Life Assurance CO Enanta Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$11.09 - $22.13 $184,149 - $367,468	-16,605 Reduced 59.28%	11,404 $127,000
Q2 2023 Aug 10, 2023	SELL	$20.68 - $39.85 $24,319 - $46,863	-1,176 Reduced 4.03%	28,009 $600,000
Q1 2023 May 12, 2023	SELL	$38.82 - $54.59 $41,886 - $58,902	-1,079 Reduced 3.57%	29,185 $1.18 Million
Q4 2022 Feb 10, 2023	BUY	$40.77 - $53.73 $272,792 - $359,507	6,691 Added 28.38%	30,264 $1.41 Million
Q3 2022 Nov 01, 2022	BUY	$48.29 - $71.27 $1.14 Million - $1.68 Million	23,573 New	23,573 $1.22 Million
Q2 2022 Aug 09, 2022	BUY	$38.13 - $76.93 $84,305 - $170,092	2,211 Added 13.97%	18,034 $853,000
Q1 2022 May 12, 2022	BUY	$56.06 - $74.11 $953 - $1,259	17 Added 0.11%	15,823 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $5,537 - $8,958	92 Added 0.59%	15,806 $1.18 Million
Q2 2021 Aug 11, 2021	BUY	$43.76 - $53.11 $1,444 - $1,752	33 Added 0.21%	15,714 $692,000
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $68,204 - $89,898	-1,636 Reduced 9.45%	15,681 $769,000
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $100,306 - $115,684	-2,437 Reduced 12.34%	17,317 $729,000
Q3 2020 Nov 17, 2020	SELL	$43.36 - $53.53 $6.01 Million - $7.42 Million	-138,536 Reduced 87.52%	19,754 $904,000
Q3 2020 Nov 13, 2020	BUY	$43.36 - $53.53 $5.99 Million - $7.4 Million	138,171 Added 686.77%	158,290 $7.25 Million
Q2 2020 Aug 17, 2020	SELL	$46.37 - $57.58 $12,937 - $16,064	-279 Reduced 1.37%	20,119 $1.01 Million
Q1 2020 May 14, 2020	BUY	$40.22 - $62.0 $36,640 - $56,482	911 Added 4.67%	20,398 $1.05 Million
Q4 2019 Feb 11, 2020	BUY	$57.95 - $66.61 $1.13 Million - $1.3 Million	19,487 New	19,487 $1.2 Million
Q3 2019 Oct 25, 2019	SELL	$60.08 - $88.17 $1.26 Million - $1.85 Million	-20,952 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$81.3 - $97.35 $10,081 - $12,071	124 Added 0.6%	20,952 $0
Q1 2019 May 08, 2019	BUY	$69.08 - $105.66 $49,668 - $75,969	719 Added 3.58%	20,828 $1.99 Million
Q4 2018 Feb 12, 2019	BUY	$65.41 - $84.65 $108,384 - $140,265	1,657 Added 8.98%	20,109 $1.31 Million
Q2 2018 Aug 10, 2018	SELL	$81.85 - $120.51 $13,505 - $19,884	-165 Reduced 0.89%	18,452 $2.14 Million
Q1 2018 May 10, 2018	SELL	$57.91 - $92.15 $70,534 - $112,238	-1,218 Reduced 6.14%	18,617 $1.51 Million
Q4 2017 Feb 09, 2018	SELL	$45.65 - $59.37 $89,291 - $116,127	-1,956 Reduced 8.98%	19,835 $1.16 Million
Q3 2017 Nov 09, 2017	BUY	$37.91 - $46.8 $826,096 - $1.02 Million	21,791	21,791 $1 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account